Skip to main content
. Author manuscript; available in PMC: 2012 Apr 22.
Published in final edited form as: Obstet Gynecol. 2010 Dec;116(6):1265–1273. doi: 10.1097/AOG.0b013e3181fc3b1a

Table 5.

List of serious adverse events (SAE) exclusive of congenital anomalies

C31G (N=10; 1.2%) Conceptrol® (N=12; 2.1%)
Anemia
Crohn’s disease
Food poisoning
Viral gastroenteritis
Cholelithiasis
Joint dislocation
Ruptured ovarian cyst
Ectopic pregnancy
Acute stress disorder
Stress incontinence
Menorrhagia
Cardiac palpitations
Diabetic ketoacidosis
E. coli gastroenteritis
Gastrointestinal pain
Nausea
Bile duct stone
Hypersensitivity to product
Pelvic inflammatory disease
Laceration (unspecified)
Hypoglycemia
Dermoid cyst
Viral meningitis
Depression
Kidney infection
Infection (unspecified)

N refers to number of subjects in each group with SAEs; some subjects reported more than one SAE.

Each of the specific SAEs listed was reported by one and only one participant.